Eissa LA - Search Results

1

Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α.

Aboismaiel MG, Amin MN, Eissa LA. Aboismaiel MG, et al. Among authors: eissa la. Biol Res. 2024 Jul 20;57(1):47. doi: 10.1186/s40659-024-00527-9. Biol Res. 2024. PMID: 39033184 Free PMC article.

2

Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.

Elsherbiny NM, Abd El Galil KH, Gabr MM, Al-Gayyar MM, Eissa LA, El-Shishtawy MM. Elsherbiny NM, et al. Among authors: eissa la. Eur Cytokine Netw. 2012 Jul-Sep;23(3):78-86. doi: 10.1684/ecn.2012.0309. Eur Cytokine Netw. 2012. PMID: 22995127 Free article.

3

Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.

Samra YA, Said HS, Elsherbiny NM, Liou GI, El-Shishtawy MM, Eissa LA. Samra YA, et al. Among authors: eissa la. Life Sci. 2016 Jul 15;157:187-199. doi: 10.1016/j.lfs.2016.06.002. Epub 2016 Jun 3. Life Sci. 2016. PMID: 27266851

4

Modulating effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through toll-like receptor 4 in type 2 diabetes mellitus.

Eraky SM, Abdel-Rahman N, Eissa LA. Eraky SM, et al. Among authors: eissa la. Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:123-129. doi: 10.1016/j.plefa.2017.06.009. Epub 2017 Jun 17. Prostaglandins Leukot Essent Fatty Acids. 2018. PMID: 28716464

5

Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.

Eissa LA, Kenawy HI, El-Karef A, Elsherbiny NM, El-Mihi KA. Eissa LA, et al. Chem Biol Interact. 2018 Oct 1;294:91-100. doi: 10.1016/j.cbi.2018.08.016. Epub 2018 Aug 21. Chem Biol Interact. 2018. PMID: 30138605

6

P-Coumaric acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor-4 in rats.

Zabad OM, Samra YA, Eissa LA. Zabad OM, et al. Among authors: eissa la. Life Sci. 2019 Dec 1;238:116965. doi: 10.1016/j.lfs.2019.116965. Epub 2019 Oct 17. Life Sci. 2019. PMID: 31629762

7

Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR-192 and miR-21.

Al-Tantawy SM, Eraky SM, Eissa LA. Al-Tantawy SM, et al. Among authors: eissa la. J Biochem Mol Toxicol. 2023 Oct;37(10):e23430. doi: 10.1002/jbt.23430. Epub 2023 Jun 23. J Biochem Mol Toxicol. 2023. PMID: 37352119

8

Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis.

Al-Tantawy SM, Eraky SM, Eissa LA. Al-Tantawy SM, et al. Among authors: eissa la. Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 19. doi: 10.1007/s00210-024-03669-5. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39702603

9

Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.

Eisa NH, ElSherbiny NM, Shebl AM, Eissa LA, El-Shishtawy MM. Eisa NH, et al. Among authors: eissa la. Cell Biochem Funct. 2015 Dec;33(8):541-51. doi: 10.1002/cbf.3153. Epub 2015 Nov 8. Cell Biochem Funct. 2015. PMID: 26548747

10

Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation.

El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, Eissa LA, El-Sherbiny IM. El-Far YM, et al. Among authors: eissa la. Nanomedicine (Lond). 2017 Jul;12(14):1689-1711. doi: 10.2217/nnm-2017-0106. Epub 2017 Jun 21. Nanomedicine (Lond). 2017. PMID: 28635562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters